US45781K2042 - ADR

2.58  +0.28 (+12.17%)

After market: 2.44 -0.14 (-5.43%)

News Image
2 months ago - Innate Pharma SA

Innate Pharma 2024 Financial Calendar

News Image
2 months ago - Seeking Alpha

Innate Pharma stock slips on FDA clinical hold (NASDAQ:IPHA)

Innate Pharma stock drops as FDA imposes partial clinical hold on two trials for lymphoma candidate lacutamab, after a fatal rare blood disorder. Read more here.

News Image
6 months ago - The Motley Fool

Why Shares of Innate Pharma Jumped Thursday

The company's collaboration agreement with Sanofi could soon pay off.

News Image
8 months ago - Seeking Alpha

Innate stock surges after license deal with Takeda (IPHA)

Innate Pharma (IPHA) stock rose ~15% after the company said it signed a license agreement with Takeda. Read more here